Back to search

University of Birmingham

Investigations into parthenolide and boronic acid oxidation towards prodrug development

Abstract

dc:description.abstract

Cancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Quy, Alexander S.

Subjects

dc:subject × 3

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Quy, Alexander S.. Investigations into parthenolide and boronic acid oxidation towards prodrug development. d_ph thesis, University of Birmingham, 2023.